Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection
Condition: HCVIntervention: Sponsor: Hoffmann-La RocheActive, not recruiting - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2015 Category: Research Source Type: clinical trials
Telaprevir in Genotype 3 HCV
Condition: Hepatitis CInterventions: Drug: Telaprevir; Drug: 40 Kd Pegylated interferon alfa 2a; Drug: RibavirinSponsors: Queen Mary University of London; Janssen-Cilag Ltd.; Barts & The London NHS Trust; St George's Healthcare NHS Trust; Bradford Teaching Hospitals NHS Foundation Trust; Nottingham University Hospitals NHS TrustNot yet recruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2014 Category: Research Source Type: clinical trials
Register of Telaprevir and Boceprevir in Routine Clinical Practice
Condition: Hepatitis CIntervention: Sponsor: Iniciativa Andaluza en Terapias Avanzadas - Fundación Pública Andaluza Progreso y SaludRecruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2013 Category: Research Source Type: clinical trials
Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1
Condition: Hepatitis C, ChronicIntervention: Drug: Telaprevir and SofosbuvirSponsors: University of Florida; Vertex Pharmaceuticals IncorporatedCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 12, 2013 Category: Research Source Type: clinical trials
Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
Condition: Hepatitis, ChronicIntervention: Sponsor: Janssen Pharmaceutica N.V., BelgiumCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2013 Category: Research Source Type: clinical trials
Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
Condition: Hepatitis, ChronicIntervention: Sponsor: Janssen Pharmaceutica N.V., BelgiumActive, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2013 Category: Research Source Type: clinical trials
Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
Condition: Hepatitis, ChronicIntervention: Sponsor: Janssen Pharmaceutica N.V., BelgiumActive, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2013 Category: Research Source Type: clinical trials
Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
Condition: Hepatitis, ChronicIntervention: Sponsor: Janssen Pharmaceutica N.V., BelgiumCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2013 Category: Research Source Type: clinical trials
Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
Condition: Hepatitis, ChronicIntervention: Sponsor: Janssen Pharmaceutica N.V., BelgiumActive, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2013 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults
Condition: Chronic Hepatitis C InfectionInterventions: Drug: ABT-450/r/ABT-267; Drug: ABT-333; Drug: Ribavrin; Drug: Pegylated Interferon alpha 2-alpha (PegINF); Drug: TelaprevirSponsor: AbbVieActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2013 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults
Condition: Chronic Hepatitis C InfectionInterventions: Drug: ABT-450/r/ABT-267; Drug: ABT-333; Drug: Ribavrin; Drug: Pegylated Interferon alpha 2-alpha (PegINF); Drug: TelaprevirSponsor: AbbVieActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2013 Category: Research Source Type: clinical trials
